bioAffinity Technologies, Inc. (BIAFW)

USD 0.22

(-20.64%)

Market Cap (In USD)

12.47 Million

Revenue (In USD)

2.53 Million

Net Income (In USD)

-7.93 Million

Avg. Volume

8442.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.3798-0.43
PE
-
EPS
-
Beta Value
3.124
ISIN
US09076W1172
CUSIP
09076W117
CIK
1712762
Shares
47932223.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Ms. Maria Zannes J.D.
Employee Count
-
Website
http://www.bioaffinitytech.com
Ipo Date
Details
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.